What do the following hormone levels indicate: progesterone 0.2 ng/mL, total estrogen 81 pg/mL, total testosterone 15 ng/dL, and free testosterone 0.8 ng/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Interpretation

These hormone levels indicate a hypoestrogenic, hypoandrogenic state with suppressed progesterone, most consistent with either early follicular phase of menstrual cycle, postmenopausal status, hypogonadotropic hypogonadism, or hormonal suppression from medications/illness.

Detailed Analysis by Hormone

Progesterone (0.2 ng/mL)

  • Markedly low, consistent with:
    • Follicular phase of menstrual cycle (normal baseline is <1 ng/mL)
    • Anovulation
    • Postmenopausal state
    • Hypogonadism
  • Normal luteal phase progesterone should exceed 12.3 ng/mL to indicate adequate ovulation 1
  • This level essentially rules out recent ovulation or pregnancy

Total Estrogen (81 pg/mL)

  • Low-normal to low, depending on menstrual cycle phase and age
  • In normally cycling premenopausal women, estradiol peaks at mid-cycle (approximately 200-400 pg/mL) 2
  • This level suggests:
    • Early follicular phase in cycling women
    • Postmenopausal range (typically <50 pg/mL, so slightly elevated if postmenopausal)
    • Hypoestrogenic state if premenopausal

Total Testosterone (15 ng/dL)

  • At the lower limit of normal for premenopausal women
  • Reference range for a 30-year-old woman: 15-46 ng/dL (5th-95th percentile) 2
  • This is the key androgen to measure per Endocrine Society guidelines 3
  • Rules out hyperandrogenism (PCOS, androgen-secreting tumors)
  • May indicate androgen deficiency if symptomatic

Free Testosterone (0.8 ng/dL or 8 pg/mL)

  • Low-normal for premenopausal women
  • Reference range: 1.2-6.4 pg/mL (5th-95th percentile) 2
  • Free testosterone is more sensitive than total testosterone for detecting androgen abnormalities 3
  • This level is below the 5th percentile if units are pg/mL, suggesting androgen deficiency
  • Note: Assay methodology matters significantly—mass spectrometry is preferred over immunoassays 4, 3

Clinical Context Required

Critical Information Needed:

  1. Age and menopausal status
  2. Day of menstrual cycle (if premenopausal and cycling)
    • Testosterone should ideally be measured in early morning, days 4-10 of cycle 3
    • Progesterone interpretation depends entirely on cycle phase
  3. Symptoms:
    • Androgen deficiency: decreased libido, fatigue, loss of muscle mass
    • Estrogen deficiency: hot flashes, vaginal dryness, irregular menses
    • Anovulation: irregular or absent menses
  4. Medications: oral contraceptives, hormone therapy, corticosteroids, anticonvulsants
  5. Medical conditions: hypothalamic amenorrhea, pituitary disorders, premature ovarian insufficiency

Most Likely Scenarios

If Premenopausal:

  • Early follicular phase (days 1-7): All values would be appropriate
  • Hypothalamic amenorrhea: from stress, excessive exercise, eating disorders
  • Hypogonadotropic hypogonadism: requires LH/FSH measurement
  • Anovulation with low androgens: atypical for PCOS

If Perimenopausal/Postmenopausal:

  • Menopausal transition: Low progesterone and testosterone expected
  • Estrogen of 81 pg/mL is higher than typical postmenopausal (<50 pg/mL)

Recommended Next Steps

  1. Obtain LH, FSH, and SHBG to determine:
    • Central (hypothalamic/pituitary) vs. peripheral (ovarian) cause
    • Calculate free androgen index if SHBG available 4
  2. Confirm timing: Repeat in early follicular phase if cycling 3
  3. Verify assay method: Mass spectrometry preferred for testosterone in women 4, 3
  4. Assess for secondary causes:
    • TSH, prolactin (if amenorrheic)
    • Nutritional status, BMI
    • Medication review

Key Pitfalls to Avoid

  • Do not interpret progesterone without knowing cycle day—it varies 100-fold across the cycle
  • Automated testosterone immunoassays are often inaccurate in the female range; use specialty labs with validated assays or mass spectrometry 3
  • Free testosterone reference ranges vary widely between laboratories; calculated free testosterone from total testosterone and SHBG is more reliable 3
  • Single measurements are insufficient—hormones fluctuate significantly, requiring clinical correlation and often repeat testing

Related Questions

In a female patient with a free testosterone level of 0.4 pg/mL, what is the clinical significance and recommended next steps?
How to normalize free testosterone and Sex Hormone-Binding Globulin (SHBG) levels in women?
In a 43-year-old woman with progesterone <0.5 ng/mL, estradiol <30 pg/mL, luteinizing hormone ≈12 IU/L, follicle‑stimulating hormone ≈9 IU/L, total testosterone 23 ng/dL, free testosterone 2.9 pg/mL, and sex hormone‑binding globulin 82 nmol/L, what is the most likely diagnosis and what is the appropriate first‑line management?
How should I evaluate and manage a 44‑year‑old woman with low free testosterone and low bioavailable testosterone, but normal total testosterone, sex hormone‑binding globulin (SHBG), follicle‑stimulating hormone (FSH), and luteinizing hormone (LH)?
In a 60-year-old male with total testosterone of 1348 ng/dL, free testosterone of 337.8 pmol/L, bioavailable testosterone of 694.6 ng/dL, estradiol of 62 pg/mL, and sex hormone‑binding globulin (SHBG) of 21 nmol/L, what is the clinical significance of these hormone levels and how should they be managed?
What is the appropriate emergency department management for a 29-year-old male with schizophrenia presenting in an acute psychotic episode who has been off clozapine for approximately six months?
What is the recommended treatment for small intestinal bacterial overgrowth (SIBO) in a patient with impaired renal function (elevated creatinine) who is on Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)?
Can hydroxyzine cause a false‑positive result on a plasma free fractionated metanephrines test?
What is the appropriate acute management for a 29-year-old male with new onset left hand weakness, focal weakness of the left wrist and fingers, and diminished sensation over the dorsal left thumb, presenting within 90 minutes of symptom onset?
What does pancytopenia indicate in a patient with suspected cancer?
Is it appropriate for a patient to split a 10 mg donepezil tablet and take 5 mg in the morning and 5 mg at night?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.